Get the Stockscreener App
20.70
5.16%
-1.09
Pulse Biosciences Inc stock is traded at $20.70, with a volume of 183.85K.
It is down -5.16% in the last 24 hours and up +11.40% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
See More
Previous Close:
$21.79
Open:
$21.97
24h Volume:
183.85K
Relative Volume:
1.06
Market Cap:
$1.33B
Revenue:
-
Net Income/Loss:
$-46.13M
P/E Ratio:
-25.48
EPS:
-0.8123
Net Cash Flow:
$-34.10M
1W Performance:
-1.27%
1M Performance:
+11.40%
6M Performance:
+50.18%
1Y Performance:
+140.29%
1-Day Range:
$20.04
$22.24
1-Week Range:
$20.01
$25.00
52-Week Range:
$6.595
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
20.65 | 1.33B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
587.00 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.97 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
90.13 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.16 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
321.11 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Pulse Biosciences Appoints Jon Skinner as Chief Financial Officer - Defense World
Pulse Biosciences (NASDAQ:PLSE) Sets New 12-Month HighHere's Why - MarketBeat
Pulse Biosciences names new CFO, continuing string of C-suite changes - MedTech Dive
Pulse Biosciences names Jon Skinner as new CFO - Investing.com India
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - BioSpace
Pulse Biosciences has a new CFO - Mass Device
Pulse Biosciences Strengthens Leadership with New CFO Appointment - TipRanks
Pulse Biosciences Names Jon Skinner CFO -February 04, 2025 at 08:54 am EST - Marketscreener.com
Pulse Biosciences Names Jon Skinner Chief Financial Officer - MarketWatch
Healthcare M&A Expert Takes CFO Role at Pulse Biosciences with $5B Growth Vision - StockTitan
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6%Time to Buy? - MarketBeat
Griffin Asset Management Inc. Sells 19,902 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
(PLSE) Technical Pivots with Risk Controls - Stock Traders Daily
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - BioSpace
Revolutionary Thyroid Treatment Gets Spotlight: Pulse Bio's Game-Changing Tech Wows Medical Experts - StockTitan
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences reports successful AF treatment in study - MSN
Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac catheter system - Cardiac Rhythm News
Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2%Here's What Happened - MarketBeat
Pulse Biosciences touts positive results from PFA early feasibility study - Yahoo Finance
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire
Pulse Biosciences' Cardiac Catheter Shows 92% Success Rate in Atrial Fibrillation Study - StockTitan
Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Barclays PLC - MarketBeat
Pulse Biosciences (NASDAQ: PLSE) Updates Investor PresentationOn January 14, 2025, Pulse Biosciences, Inc., a Delaware corporation, announced that it has posted an updated investor presentation on its website. The revised investor presentation, known - Defense World
Pulse Biosciences Updates Investors on Cardiac Innovations - TipRanks
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium - BioSpace
Pulse Biosciences' Breakthrough nsPFA Cardiac Catheter to Headline AF Symposium 2025 - StockTitan
Jane Street Group LLC Has $233,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences announces CEO appointment - MSN
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer - BioSpace
Pulse Biosciences names Paul LaViolette as CEO By Investing.com - Investing.com Canada
Pulse Biosciences names Paul LaViolette as CEO - Investing.com India
Pulse Biosciences Appoints Co-Chairman Paul LaViolette as CEO - MarketWatch
Pulse Biosciences Names Boston Scientific Veteran LaViolette as CEO, Advances Cardiac Tech Pipeline - StockTitan
Pulse Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
Pulse Biosciences (NASDAQ:PLSE) Trading 6.1% HigherShould You Buy? - MarketBeat
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Pulse Biosciences to Present Nano-PFA Technology at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Barclays PLC Buys 23,738 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Geode Capital Management LLC - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Upgraded to "Sell" at StockNews.com - MarketBeat
Franklin Resources Inc. Buys New Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulse Biosciences Inc Stock (PLSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
| Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):